Xenetic Biosciences, Inc. (XBIO)
4.20
-0.08
(-1.87%)
USD |
NASDAQ |
Sep 09, 16:00
4.20
0.00 (0.00%)
After-Hours: 16:08
Xenetic Biosciences Shareholders Equity (Quarterly) : 6.073M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 6.073M |
| March 31, 2026 | 6.951M |
| December 31, 2025 | 7.396M |
| September 30, 2025 | 3.956M |
| June 30, 2025 | 4.450M |
| March 31, 2025 | 5.123M |
| December 31, 2024 | 6.007M |
| September 30, 2024 | 7.037M |
| June 30, 2024 | 7.446M |
| March 31, 2024 | 8.678M |
| December 31, 2023 | 9.796M |
| September 30, 2023 | 10.89M |
| June 30, 2023 | 11.88M |
| March 31, 2023 | 12.86M |
| December 31, 2022 | 13.65M |
| September 30, 2022 | 14.52M |
| June 30, 2022 | 15.19M |
| March 31, 2022 | 16.92M |
| December 31, 2021 | 18.39M |
| September 30, 2021 | 20.16M |
| June 30, 2021 | 9.949M |
| March 31, 2021 | 10.95M |
| December 31, 2020 | 12.22M |
| September 30, 2020 | 7.908M |
| June 30, 2020 | 15.36M |
| Date | Value |
|---|---|
| March 31, 2020 | 16.20M |
| December 31, 2019 | 17.21M |
| September 30, 2019 | 18.26M |
| June 30, 2019 | 10.39M |
| March 31, 2019 | 11.52M |
| December 31, 2018 | 9.913M |
| September 30, 2018 | 11.30M |
| June 30, 2018 | 12.78M |
| March 31, 2018 | 12.89M |
| December 31, 2017 | 14.30M |
| September 30, 2017 | 9.555M |
| June 30, 2017 | 11.51M |
| March 31, 2017 | 13.90M |
| December 31, 2016 | 16.17M |
| September 30, 2016 | 5.954M |
| June 30, 2016 | 6.412M |
| March 31, 2016 | 5.061M |
| December 31, 2015 | 6.609M |
| September 30, 2015 | 5.183M |
| June 30, 2015 | 6.834M |
| March 31, 2015 | 8.209M |
| December 31, 2014 | 10.48M |
| September 30, 2014 | 14.02M |
| June 30, 2014 | 17.49M |
| March 31, 2014 | 19.81M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 465.53M |
| Oncolytics Biotech, Inc. | -6.167M |
| Sangamo Therapeutics, Inc. | -18.96M |
| Sarepta Therapeutics, Inc. | 1.528B |
| Anixa Biosciences, Inc. | 14.48M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 6.968M |
| Total Liabilities (Quarterly) | 0.895M |
| Current Ratio | 7.435 |